Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: Male

Summary

To evaluate the effects of a 14-day repeated dose of 150 mg bupropion (therapeutic dose) on cognitive and executive functions, behaviour and subjective feelings, after sleep deprivation in 12 healthy male subjects.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital, Montpellier
• Treatments: Bupropion

Criteria

Inclusion Criteria:

• BMI between 20.0 and 25.00

• no smoker

Exclusion Criteria:

-